| scholarly article | Q13442814 |
| P50 | author | Stephanie A. Smith | Q46924869 |
| James H Morrissey | Q57024638 | ||
| P2093 | author name string | Sharon H Choi | |
| P2860 | cites work | Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo | Q24655664 |
| The gene for a major exopolyphosphatase of Saccharomyces cerevisiae | Q27931670 | ||
| Inorganic polyphosphate: a molecule of many functions | Q28139415 | ||
| Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis | Q28508572 | ||
| Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces | Q28630174 | ||
| Factor XII-independent activation of factor XI in plasma: effects of sulfatides on tissue factor-induced coagulation | Q28631206 | ||
| Thrombin activates factor XI on activated platelets in the absence of factor XII | Q28631554 | ||
| Silver stain for proteins in polyacrylamide gels: A modified procedure with enhanced uniform sensitivity | Q29615342 | ||
| Activated factor V is a cofactor for the activation of factor XI by thrombin in plasma. | Q33927262 | ||
| Role of blood coagulation factor XI in downregulation of fibrinolysis | Q34015832 | ||
| Direct labeling of polyphosphate at the ultrastructural level in Saccharomyces cerevisiae by using the affinity of the polyphosphate binding domain of Escherichia coli exopolyphosphatase | Q34098041 | ||
| Factor XI deficiency in Ashkenazi Jews in Israel | Q34118794 | ||
| WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING. | Q34257361 | ||
| Phosphoramidate end labeling of inorganic polyphosphates: facile manipulation of polyphosphate for investigating and modulating its biological activities | Q34293215 | ||
| Polyphosphate modulates blood coagulation and fibrinolysis. | Q34304738 | ||
| Human platelet dense granules contain polyphosphate and are similar to acidocalcisomes of bacteria and unicellular eukaryotes. | Q34340830 | ||
| Polyphosphate exerts differential effects on blood clotting, depending on polymer size. | Q34360392 | ||
| Factor XI activation in a revised model of blood coagulation | Q34500136 | ||
| Activation of factor XI by products of prothrombin activation | Q35112259 | ||
| Feedback activation of factor XI by thrombin does not occur in plasma | Q35921705 | ||
| Polyphosphate enhances fibrin clot structure | Q36915892 | ||
| Factor XI contributes to thrombin generation in the absence of factor XII | Q37271059 | ||
| Fibrinogen blocks the autoactivation and thrombin-mediated activation of factor XI on dextran sulfate | Q37312644 | ||
| Structural and functional features of factor XI. | Q37561457 | ||
| Factor XI deficiency--resolving the enigma? | Q37653157 | ||
| Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis | Q39784189 | ||
| Polyphosphate binds with high affinity to exosite II of thrombin. | Q40092357 | ||
| Inorganic polyphosphate in mammalian cells and tissues | Q42829243 | ||
| Variable bleeding manifestations characterize different types of surgery in patients with severe factor XI deficiency enabling parsimonious use of replacement therapy | Q45861849 | ||
| Plasma thromboplastin antecedent (PTA) deficiency; clinical, coagulation, therapeutic and hereditary aspects of a new hemophilia-like disease. | Q45865893 | ||
| Factor XI-dependent reciprocal thrombin generation consolidates blood coagulation when tissue factor is not available. | Q45874409 | ||
| Roles of platelets and factor XI in the initiation of blood coagulation by thrombin. | Q55034971 | ||
| Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor XI-deficient kindreds | Q69865005 | ||
| Effects of glycosaminoglycans on factor XI activation by thrombin | Q70622274 | ||
| Sulfatide-dependent autoactivation of human blood coagulation Factor XII (Hageman Factor) | Q70828892 | ||
| When and where is factor XI activated by thrombin? | Q71087738 | ||
| The interaction of factor XIa with activated platelets but not endothelial cells promotes the activation of factor IX in the consolidation phase of blood coagulation | Q74588342 | ||
| Specific localization of inorganic polyphosphate (poly P) in fungal cell walls by selective extraction and immunohistochemistry | Q79826424 | ||
| Reduced incidence of ischemic stroke in patients with severe factor XI deficiency | Q80681812 | ||
| Feedback controversy stops here | Q84202652 | ||
| P433 | issue | 26 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 6963-6970 | |
| P577 | publication date | 2011-10-05 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Polyphosphate is a cofactor for the activation of factor XI by thrombin | |
| P478 | volume | 118 |
| Q35637441 | 2013 scientific sessions Sol Sherry distinguished lecture in thrombosis: polyphosphate: a novel modulator of hemostasis and thrombosis. |
| Q38798595 | A flow cytometry-based assay for procoagulant platelet polyphosphate |
| Q55260308 | Ability of Polyphosphate and Nucleic Acids to Trigger Blood Clotting: Some Observations and Caveats. |
| Q88670342 | Abnormal plasma clot formation and fibrinolysis reveal bleeding tendency in patients with partial factor XI deficiency |
| Q46272142 | Acquisition of the phosphate transporter NptA enhances Staphylococcus aureus pathogenesis by improving phosphate uptake in divergent environments. |
| Q35126274 | Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor |
| Q35920828 | Allosteric inhibition of factor XIa. Sulfated non-saccharide glycosaminoglycan mimetics as promising anticoagulants |
| Q47311661 | An update on factor XI structure and function |
| Q34153581 | Analysis of the factor XI variant Arg184Gly suggests a structural basis for factor IX binding to factor XIa |
| Q38728228 | Aspirin therapy reduces the ability of platelets to promote colon and pancreatic cancer cell proliferation: Implications for the oncoprotein c-MYC. |
| Q38082468 | Bench to bedside: new developments in our understanding of the pathophysiology of thrombosis |
| Q47304447 | Bone-targeting poly(ethylene sodium phosphate). |
| Q55052361 | Cell Receptor and Cofactor Interactions of the Contact Activation System and Factor XI. |
| Q27027361 | Complement-Coagulation Cross-Talk: A Potential Mediator of the Physiological Activation of Complement by Low pH |
| Q38108527 | Current state of knowledge on oral anticoagulant reversal using procoagulant factors |
| Q52355812 | Design of Polyphosphate Inhibitors: A Molecular Dynamics Investigation on Polyethylene Glycol-Linked Cationic Binding Groups. |
| Q34435690 | Designing allosteric inhibitors of factor XIa. Lessons from the interactions of sulfated pentagalloylglucopyranosides |
| Q37390247 | Desmolaris, a novel factor XIa anticoagulant from the salivary gland of the vampire bat (Desmodus rotundus) inhibits inflammation and thrombosis in vivo |
| Q39117235 | Differential Roles for the Coagulation Factors XI and XII in Regulating the Physical Biology of Fibrin. |
| Q102143475 | Discovery of Benzyl Tetraphosphonate Derivative as Inhibitor of Human Factor Xia |
| Q42725749 | Dynamics of Thrombin Generation and Flux from Clots during Whole Human Blood Flow over Collagen/Tissue Factor Surfaces |
| Q45863678 | Evaluation of the use of rotational thromboelastometry in the assessment of FXI deficiency |
| Q36070475 | FXIa and platelet polyphosphate as therapeutic targets during human blood clotting on collagen/tissue factor surfaces under flow |
| Q27024190 | Factor XI and contact activation as targets for antithrombotic therapy |
| Q36024822 | Factor XI and factor XII as targets for new anticoagulants |
| Q37398521 | Factor XI anion-binding sites are required for productive interactions with polyphosphate. |
| Q57824341 | Factor XII Activation Promotes Platelet Consumption in the Presence of Bacterial-Type Long-Chain Polyphosphate In Vitro and In Vivo |
| Q37022061 | Factor XII promotes blood coagulation independent of factor XI in the presence of long-chain polyphosphates. |
| Q38587540 | Factor XII: a novel target for safe prevention of thrombosis and inflammation |
| Q89036008 | From underlying chemistry to therapeutic potential: open questions in the new field of lysine polyphosphorylation |
| Q50566748 | Generation and characterization of aptamers targeting factor XIa. |
| Q58192117 | Glandular Matrices and Secretions: Blood-Feeding Arthropods |
| Q27301794 | Identification and Mechanistic Analysis of a Novel Tick-Derived Inhibitor of Thrombin |
| Q34300714 | In vivo roles of factor XII. |
| Q64099060 | Inhibition of contact-mediated activation of factor XI protects baboons against S aureus–induced organ damage and death |
| Q36509624 | Inhibition of polyphosphate as a novel strategy for preventing thrombosis and inflammation |
| Q89180802 | Inorganic Polyphosphate Amplifies High Mobility Group Box 1-Mediated Von Willebrand Factor Release and Platelet String Formation on Endothelial Cells |
| Q35582599 | Inorganic polyphosphate elicits pro-inflammatory responses through activation of the mammalian target of rapamycin complexes 1 and 2 in vascular endothelial cells |
| Q42755826 | Inorganic polyphosphate promotes cyclin D1 synthesis through activation of mTOR/Wnt/β-catenin signaling in endothelial cells |
| Q34990211 | Inorganic polyphosphate suppresses lipopolysaccharide-induced inducible nitric oxide synthase (iNOS) expression in macrophages |
| Q39031470 | Inorganic polyphosphate: a key modulator of inflammation |
| Q48175284 | Interferon lambda1/IL-29 and inorganic polyphosphate are novel regulators of neutrophil-driven thromboinflammation. |
| Q42011864 | Localization of Short-Chain Polyphosphate Enhances its Ability to Clot Flowing Blood Plasma. |
| Q97520716 | Mechanisms and biomarkers of cancer-associated thrombosis |
| Q35708531 | Modular Small Diameter Vascular Grafts with Bioactive Functionalities |
| Q37261059 | Neutralizing blood-borne polyphosphate in vivo provides safe thromboprotection |
| Q55652396 | New players in haemostasis and thrombosis. |
| Q27680138 | Novel Family of Insect Salivary Inhibitors Blocks Contact Pathway Activation by Binding to Polyphosphate, Heparin, and Dextran Sulfate |
| Q36167707 | Nucleic acid scavengers inhibit thrombosis without increasing bleeding. |
| Q89913060 | Nucleic acids as cofactors for factor XI and prekallikrein activation: Different roles for high-molecular-weight kininogen |
| Q51263915 | Paradoxical bleeding and thrombotic episodes of dysprothrombinaemia due to a homozygous Arg382His mutation. |
| Q37262537 | Plasma DNA is Elevated in Patients with Deep Vein Thrombosis |
| Q90745378 | Plasma contact factors as therapeutic targets |
| Q36169665 | Platelet-Derived Short-Chain Polyphosphates Enhance the Inactivation of Tissue Factor Pathway Inhibitor by Activated Coagulation Factor XI. |
| Q26820857 | Platelet-based coagulation: different populations, different functions |
| Q53721304 | Polyphosphate accelerates factor V activation by factor XIa. |
| Q48122836 | Polyphosphate and RNA Differentially Modulate the Contact Pathway of Blood Clotting. |
| Q64118859 | Polyphosphate as a Target for Interference With Inflammation and Thrombosis |
| Q35835056 | Polyphosphate as modulator of hemostasis, thrombosis, and inflammation |
| Q36003987 | Polyphosphate elicits pro-inflammatory responses that are counteracted by activated protein C in both cellular and animal models |
| Q41877238 | Polyphosphate in Neonates: Less Shedding from Platelets and Divergent Prothrombotic Capacity Due to Lower TFPI Levels |
| Q41323819 | Polyphosphate multi-tasks |
| Q48098873 | Polyphosphate nanoparticles on the platelet surface trigger contact system activation |
| Q35040991 | Polyphosphate-mediated inhibition of tartrate-resistant acid phosphatase and suppression of bone resorption of osteoclasts |
| Q35991866 | Polyphosphate: a link between platelets, coagulation and inflammation |
| Q35556300 | Polyphosphate: a new player in the field of hemostasis |
| Q26865798 | Polyphosphate: an ancient molecule that links platelets, coagulation, and inflammation |
| Q47702346 | Prochemerin cleavage by factor XIa links coagulation and inflammation |
| Q50961053 | Proteolytic properties of single-chain factor XII: a mechanism for triggering contact activation. |
| Q40937254 | Quality of factor XI activity testing in North American Specialized Coagulation Laboratories |
| Q50499084 | Red blood cell-derived microparticles isolated from blood units initiate and propagate thrombin generation. |
| Q26828498 | Role of β-hydroxybutyrate, its polymer poly-β-hydroxybutyrate and inorganic polyphosphate in mammalian health and disease |
| Q34547334 | Sulfated pentagalloylglucoside is a potent, allosteric, and selective inhibitor of factor XIa |
| Q34033754 | Synthesis and evaluation of chromogenic and fluorogenic substrates for high-throughput detection of enzymes that hydrolyze inorganic polyphosphate. |
| Q28083939 | TACTIC: Trans-Agency Consortium for Trauma-Induced Coagulopathy |
| Q42792418 | Targeting factor XI to prevent thrombosis |
| Q91788761 | The contact pathway and sepsis |
| Q36833564 | The dimeric structure of factor XI and zymogen activation |
| Q38840382 | The hemostatic role of factor XI. |
| Q38106741 | The kinin-kallikrein system: physiological roles, pathophysiology and its relationship to cancer biomarkers. |
| Q33597260 | The mechanism underlying activation of factor IX by factor XIa. |
| Q37108888 | Why factor XI deficiency is a clinical concern |
Search more.